Atlas Trials

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Clinical trial NCT04563507 · RECRUITING

Trial details

NCT number
NCT04563507
Sponsor
Weill Medical College of Cornell University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-11-12
Primary completion
2027-10-31
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.